GSK entered into a buy-in deal with Prudential in November of last year. Martin Mannion from GSK said, "I don't think the deal was physically possible without a transition manager because you had potential contracts you were entering into, you were attempting to hedge, you were attempting to buy into their wish-list ahead of time... So I think that's in the category of ‘don't even go there without a TM'."
The transition event lasted nine months.
Read the full article here.
Sovereign Investor: Do you use transition managers? Do you use a single firm or have access to a panel?
No comments:
Post a Comment